📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Type 1 interferon auto-antibodies are elevated in patients with decompensated liver cirrhosis. (2024)

First Author: Greville G

Attributed to: Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced Disease funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cei/uxad119

PubMed Identifier: 37917972

Publication URI: http://europepmc.org/abstract/MED/37917972

Type: Journal Article/Review

Volume: 215

Parent Publication: Clinical and experimental immunology

Issue: 2

ISSN: 0009-9104